ESC Premium Access

Patterns of use of prasugrel or clopidogrel in elderly patients in the "real world" from the PROMETHEUS registry

Congress Session

About the speaker

Doctor Mark Effron

Eli Lilly and Company, Indianapolis, IN (United States of America)
0 follower

24 more presentations in this session

Effect of pretreatment with P2Y12 receptor antagonists on mortality in patients undergoing PCI: A report from SCAAR

Speaker: Professor E. Omerovic (Gothenburg, SE)

Thumbnail

Gender differences in oral antiplatelet treatment use - results from a nationwide cohort study of acute coronary syndrome patients in Finland

Speaker: Doctor V. Kyto (Turku, FI)

Thumbnail

Prevalence and outcomes of prasugrel versus clopidogrel in patients with and without diabetes following percutaneous coronary intervention for acute coronary syndrome

Speaker: Doctor M. Faggioni (Nashville, US)

Thumbnail

Platelet reactivity and outcomes after transcatheter aortic valve implantation

Speaker: Doctor L. Gross (Munich, DE)

Thumbnail

Safety of a regional standardized protocol to optimize the use of most effective platelet inhibition in ACS treated with PCI : Final Results from the Multicenter Rijnmond Collective Cardiology Study

Speaker: Doctor M. Van Der Linden (Schiedam, NL)

Thumbnail

Access the full session

Poster session 2 - Clinical platelet studies

Speakers: Doctor M. Effron, Professor E. Omerovic, Doctor V. Kyto, Doctor M. Faggioni, Doctor L. Gross...
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk